Antares Pharma reported $5.39M in EBIT for its first fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Abbott ABT:US $ 2331M 232M
Adamas Pharmaceuticals ADMS:US -9525000 5.45M
Adma Biologics ADMA:US $ -15164250 2.06M
Aerie Pharmaceuticals AERI:US $ -34219000 1.37M
Ani Pharmaceuticals ANIP:US $ 3.08M 582K
Antares Pharma ATRS:US $ 5.39M 707K
Becton, Dickinson and BDX:US $ 852M 460M
Biodelivery Sciences International BDSI:US $ 7.44M 5.08M
Cara Therapeutics CARA:US $ -23561000 101.85M
Cerus CERS:US $ -16447000 2.11M
Eli Lilly And LLY:US $ 1666.2M 662.1M
Endo International Ordinary Shares ENDP:US $ 219.43M 43.78M
Horizon Pharma HZNP:US -89446000 326.97M
JAZZ PHA JAZZ:US 162.12M 11.3M
Orasure Technologies OSUR:US $ 9.62M 1.73M
Pacira Pharmaceuticals PCRX:US $ 21.31M 4.24M
Pfizer PFE:US $ 5757M 4605M
Revance Therapeutics RVNC:US $ -70012000 7.96M
Sientra SIEN:US $ -9820000 7.3M
Staar Surgical STAA:US $ 7.47M 3.39M
Supernus Pharmaceuticals SUPN:US $ 13.21M 29.88M
Teva Pharmaceutical TEVA:IT 794M 12M
Teva Pharmaceutical Industries TEVA:US 794M 12M